A phase II study of ganetespib (G) as second- or third-line therapy for metastatic pancreatic cancer (MPC).

被引：1
|
作者：
Thota, Ramya
Goff, Laura Williams
Chan, Emily
Berlin, Jordan
Jones, C. Michael
McClanahan, Pamela
Ayers, Gregory Dan
Cardin, Dana Backlund
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Jones Clin, Germantown, TN USA
[5] Vanderbilt Univ, Div Canc Biostat, Nashville, TN 37235 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.297
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
    Kang, Yoon-Koo
    Muro, Kei
    Ryu, Min-Hee
    Yasui, Hirofumi
    Nishina, Tomohiro
    Ryoo, Baek-Yeol
    Kamiya, Yukimasa
    Akinaga, Shiro
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 355 - 361
  • [22] A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
    Yoon-Koo Kang
    Kei Muro
    Min-Hee Ryu
    Hirofumi Yasui
    Tomohiro Nishina
    Baek-Yeol Ryoo
    Yukimasa Kamiya
    Shiro Akinaga
    Narikazu Boku
    Investigational New Drugs, 2014, 32 : 355 - 361
  • [23] Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer
    Brodowicz, T
    Koestler, WJ
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (03) : 149 - 153
  • [24] Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer
    Huo, Gengwei
    Liu, Wenjie
    Chen, Peng
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (05)
  • [25] Is there a third-line therapy for metastatic colorectal cancer?
    Grothey, Axel
    SEMINARS IN ONCOLOGY, 2006, 33 (06) : S36 - S38
  • [26] Third-Line Therapy in Metastatic Colorectal Cancer
    van de Haar, Joris
    Valeri, Nicola
    Voest, Emile E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (02): : 190 - 191
  • [27] Third-line therapy for metastatic colorectal cancer
    M. G. Gundgaard
    J. B. Soerensen
    E. Ehrnrooth
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 1 - 13
  • [28] Third-line therapy for metastatic colorectal cancer
    Gundgaard, M. G.
    Soerensen, J. B.
    Ehrnrooth, E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 1 - 13
  • [29] PHASE II STUDY OF OXALIPLATIN AS THIRD-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Sikder, S. K.
    Rahman, M.
    Saha, R. K.
    ANNALS OF ONCOLOGY, 2010, 21 : 219 - 219
  • [30] Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Woo, Kaitlin
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    LUNG CANCER, 2014, 84 (03) : 271 - 274
12345